ID
42598
Description
Study ID: 101468/201 Clinical Study ID: 101468/201 Study Title: A Single Blind, Parallel Group, Up-titration, Phase 1 Study in Healthy Volunteers to Determine a Starting Dose and Select an Up-titration Regimen for a new Formulation of Ropinirole Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Restless Legs Syndrome The Study consists of 21 Visits(Days): Screening (at least 21 days before dosing) Week 1: including Day 1-7 Week 2: including Day 8-14 Week 3: including Day 15-19 Follow-up Visit (7-14 days after last dose) This document contains the Significant Medical/ Surgical History And Physical Examination and the Prior Medication form. It has to be filled in for screening.
Mots-clés
Versions (4)
- 01/09/2017 01/09/2017 -
- 18/06/2019 18/06/2019 -
- 18/06/2019 18/06/2019 -
- 17/09/2021 17/09/2021 -
Détendeur de droits
GlaxoSmithKline
Téléchargé le
17 septembre 2021
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Determination of starting dose and up-titration regimen for a new formulation of Ropinirole in healthy adults, 101468/201
Significant Medical/ Surgical History And Physical Examination, Prior Medication
Description
Significant Medical/ Surgical History And Physical Examination
Alias
- UMLS CUI-1
- C0262926
- UMLS CUI-2
- C0031809
Description
If you tick Yes, fill in the follwoing items for each diagnosis. Only in the absence of a diagnosis, record the signs and symptoms on separate lines.
Type de données
text
Alias
- UMLS CUI [1]
- C1699700
- UMLS CUI [2]
- C0543467
Description
Diagnosis
Type de données
text
Alias
- UMLS CUI [1]
- C0011900
Description
Month Year
Type de données
partialDate
Alias
- UMLS CUI [1,1]
- C0439234
- UMLS CUI [1,2]
- C0011900
Description
Medical condition
Type de données
text
Description
Prior Medication
Alias
- UMLS CUI-1
- C2826257
Description
If you tick ‘Yes’, please record each medication in the following items.
Type de données
text
Alias
- UMLS CUI [1]
- C2826257
Description
(Trade name preferred)
Type de données
text
Alias
- UMLS CUI [1]
- C2360065
Description
(eg 500 mg)
Type de données
text
Alias
- UMLS CUI [1]
- C1960417
Description
(eg BID, PRN)
Type de données
text
Alias
- UMLS CUI [1]
- C3476109
Description
Other routes may be entered onto the form when appropriate, and will be coded prior to data entry.
Type de données
text
Alias
- UMLS CUI [1]
- C0013153
Description
Indication on Prior Medication page must correlate utilizing the same terminology. Indication on Concomitant page must be recorded on the Adverse Events Page and expressed utilizing the same terminology.
Type de données
text
Alias
- UMLS CUI [1,1]
- C3146298
- UMLS CUI [1,2]
- C0013227
Description
(e.g. 6 years)
Type de données
text
Alias
- UMLS CUI [1]
- C0444921
Description
day month year. If therapy/medication is continuing tick the follwing item.
Type de données
date
Alias
- UMLS CUI [1,1]
- C0087111
- UMLS CUI [1,2]
- C0806020
- UMLS CUI [2,1]
- C0013227
- UMLS CUI [2,2]
- C0806020
Description
If a medication was marked continuing at the initial visit (on the Prior and Concomitant Medication Page), but has since had a dosage change or has been stopped, it must be recorded on this form as a change with the start and end date.
Type de données
text
Alias
- UMLS CUI [1]
- C1553904
Similar models
Significant Medical/ Surgical History And Physical Examination, Prior Medication
C0031809 (UMLS CUI-2)
C0543467 (UMLS CUI [2])
C0011900 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C0013227 (UMLS CUI [2,1])
C0806020 (UMLS CUI [2,2])
Aucun commentaire